Background: Most patients with respiratory syncytial virus (RSV) infection requiring hospitalization have no risk factors for severe disease. Genetic variation in the receptor for the Fc portion of IgG (FcγR) determines their affinity for IgG subclasses driving innate and adaptive antiviral immunity. We investigated the relationship between FcγRIIa-H131R polymorphism and RSV disease. Methods: Blood samples were collected from 182 infants ≤24-month-old (50 uninfected, 114 RSV-infected with moderate course and 18 suffering severe disease). FcγRIIa-H131R SNP genotypic frequencies (HH, HR, RR) and anti-RSV IgG1, IgG2 and IgG3 levels were studied. Results: Genotypic frequencies for FcγRIIa-H131R SNP were comparable between uninfected and RSV-infected infants. In contrast, we found a significant higher frequency of HH genotype in severe RSV-infected children compared to moderate patients. Among severe group, HH infants presented more factors associated to severity than HR or RR patients did. Furthermore, compared to moderate RSV-infected infants, severe patients showed higher levels of anti-RSV IgG1 and IgG3. Conclusions: We found an association between an FcγRIIa (H131) polymorphism and severe RSV disease, which points towards a critical role for interactions between FcγRs and immune complexes in RSV pathogenesis. This genetic factor could also predict the worse outcome and identify those infants at risk during hospitalization.
Background: Most patients with respiratory syncytial virus (RSV) infection requiring hospitalization have no risk factors for severe disease. Genetic variation in the receptor for the Fc portion of IgG (FcγR) determines their affinity for IgG subclasses driving innate and adaptive antiviral immunity. We investigated the relationship between FcγRIIa-H131R polymorphism and RSV disease. Methods: Blood samples were collected from 182 infants ≤24-month-old (50 uninfected, 114 RSV-infected with moderate course and 18 suffering severe disease). FcγRIIa-H131R SNP genotypic frequencies (HH, HR, RR) and anti-RSV IgG1, IgG2 and IgG3 levels were studied. Results: Genotypic frequencies for FcγRIIa-H131R SNP were comparable between uninfected and RSV-infected infants. In contrast, we found a significant higher frequency of HH genotype in severe RSV-infected children compared to moderate patients. Among severe group, HH infants presented more factors associated to severity than HR or RR patients did. Furthermore, compared to moderate RSV-infected infants, severe patients showed higher levels of anti-RSV IgG1 and IgG3. Conclusions: We found an association between an FcγRIIa (H131) polymorphism and severe RSV disease, which points towards a critical role for interactions between FcγRs and immune complexes in RSV pathogenesis. This genetic factor could also predict the worse outcome and identify those infants at risk during hospitalization.
Authors: Cristian A Galván; Osvaldo C Elbarcha; Eduardo J Fernández; Dante M Beltramo; Néstor W Soria Journal: Clin Biochem Date: 2011-06-24 Impact factor: 3.281
Authors: R G Westendorp; J A Langermans; T W Huizinga; A H Elouali; C L Verweij; D I Boomsma; J P Vandenbroucke; J P Vandenbrouke Journal: Lancet Date: 1997-01-18 Impact factor: 79.321
Authors: Cesar Mella; M Carmen Suarez-Arrabal; Santiago Lopez; Julie Stephens; Soledad Fernandez; Mark W Hall; Octavio Ramilo; Asuncion Mejias Journal: J Infect Dis Date: 2012-11-29 Impact factor: 5.226
Authors: L A Sanders; J G van de Winkel; G T Rijkers; M M Voorhorst-Ogink; M de Haas; P J Capel; B J Zegers Journal: J Infect Dis Date: 1994-10 Impact factor: 5.226
Authors: Roberto S Gómez; Bruno A Ramirez; Pablo F Céspedes; Kelly M Cautivo; Sebastián A Riquelme; Carolina E Prado; Pablo A González; Alexis M Kalergis Journal: Immunology Date: 2015-11-06 Impact factor: 7.397
Authors: Maximillian S Habibi; Agnieszka Jozwik; Spyridon Makris; Jake Dunning; Allan Paras; John P DeVincenzo; Cornelis A M de Haan; Jens Wrammert; Peter J M Openshaw; Christopher Chiu Journal: Am J Respir Crit Care Med Date: 2015-05-01 Impact factor: 30.528
Authors: Orlando A Acevedo; Fabián E Díaz; Tomas E Beals; Felipe M Benavente; Jorge A Soto; Jorge Escobar-Vera; Pablo A González; Alexis M Kalergis Journal: Front Cell Infect Microbiol Date: 2019-03-29 Impact factor: 5.293
Authors: Fernando P Polack; Michael N Teng; Peter L Collins; Gregory A Prince; Marcus Exner; Heinz Regele; Dario D Lirman; Richard Rabold; Scott J Hoffman; Christopher L Karp; Steven R Kleeberger; Marsha Wills-Karp; Ruth A Karron Journal: J Exp Med Date: 2002-09-16 Impact factor: 14.307